© 2022 Michigan State University Board of Trustees
Public Media from Michigan State University
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Neurontin

Michele Norris talks with NPR's Snigdha Prakash about actions by drug company Parke-Davis to promote the drug Neurontin for uses not yet approved by the government. NPR has obtained documents indicating that Tony Wild, then-president of Parke-Davis, was aware of the plan to work around FDA approval to promote the drug.

Copyright 2002 NPR

News from WKAR will never be behind a paywall. Ever. We need your help to keep our coverage free for everyone. Please consider supporting the news you rely on with a donation today. You can support our journalism for as little as $5. Every contribution, no matter the size, propels our vital coverage. Thank you.